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Objectives: To report early and late outcomes of
segmental resection and graft replacement of the inferior
vena cava (IVC) for malignant disease.
Methods: All patients who had IVC resection with
graft reconstruction from 1990 to 2013 were reviewed. Pa-
tients with tangential excision and primary or patch venor-
rhaphy were excluded. End points were early (<30 days)
mortality, major adverse events (MAE), graft-related com-
plications, primary patency, and recurrence-free and overall
survival.
Results: Among 2305 patients treated for retroperito-
neal malignancy, 102 (50% male; age, 56 6 15 years) had
IVC resection and graft replacement (prosthetic in 100).
Primary leiomyosarcoma occurred in 33 patients (32%)
and other malignancies in 69 (68%; P < .0001). Preopera-
tive performance status (Eastern Cooperative Oncology
Group) was good or excellent in 92 patients (90%). Resec-
tion of multiple IVC segments was required in 59 patients
(58%), 24 who needed renal vein reconstruction (24%) and
two who had hepatic vein reimplantation. One patient died
of intraoperative hemorrhage. Four others died #4
months, one procedure-related from duodenal leak and
multisystem organ failure. Fifteen patients had MAE
(15%), two graft-related. Over a mean follow-up of 56
months, seven patients had graft occlusion (6.9%). At 5-
years, overall survival was 51% (range, 1-214 months), local
recurrence-free survival was 66%, and disease-free survival
was 35%. Four patients underwent graft-related reinterven-
tions (4%). Kaplan-Meier estimates of IVC graft primary
patency were 95%, 92%, and 92% at 1, 3, and 5 years,
respectively.
Conclusions: IVC resection and graft replacement for
malignant disease is safe, durable and provides excellent
local control of the tumor in select patients.
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Type Ia Endoleaks Following Fenestrated and
Branched Endografts May Lead to component
instability and increased mortality
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Objectives: Fenestrated and branched endografts
facilitate sealing in the visceral aorta to extend the landing
zone for complex aneurysms. We describe the causes and
implications of proximal endoleak in our experience.
Methods: All patients undergoing fenestrated/
branched repair were entered onto a prospective database.
Inclusion criteria necessitated the availability of at least one
postoperative contrast computed tomography scan. Three-
dimensional imaging was used to characterize morphology
and correlated with outcome. Blinded assessors resized the
repairs in the endoleak group to assess the change in prac-
tice from early repairs to current practice. Outcome mea-
sures were mortality and a composite of stent fracture,
type III and Ic endoleak, as an indicator of device stability.
Results: Up to July 2013, 969 patients underwent
fenestrated/branched repair. Emergency repairs (n ¼ 24)
and patients without requisite imaging (n ¼ 21) were
excluded, leaving 924 available for analysis. A type Ia endo-
leak was identiﬁed in 23 patients (2.5%). Landing zone
choice was implicated as cause of endoleak development,
because sealing in the visceral aorta was associated with endo-
leak development (52.2% vs 24.5%, P ¼ .006). Aortic-related
mortality was higher in the endoleak group, 30% vs 7%
respectively (P ¼ .001), and they experienced a higher inci-
dence of component instability, 34.8 vs 9.5% (P ¼ .001).
Conclusions: Fenestrated/branched endovascular
repair has a low incidence of sealing zone failure despite
the increased complexity. Choice of proximal landing
zone may predict occurrence of endoleak. Development
of a proximal endoleak seems to destabilize the repair
and may lead to increased mortality.
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Objectives: Endovascular aneurysm repair (EVAR)
has become the primary treatment for abdominal aortic
